Control of HIV after Antiretroviral Medication Pause (CHAMP)
-
Principal Investigator(s): Jonathan Li
-
Study Contact: Jonathan Li, jli@bwh.harvard.edu
-
Description of Subjects: Post-treatment controllers
-
Location (Domestic vs. International): United States, Canada
-
Enrollment Period: n/a
-
Enrollment Goal: 200
-
Key Exclusion and Inclusion Criteria: Discontinued antiretroviral therapy with viral loads <=400 HIV-1 RNA copies/mL at 2/3 of time points for at least 24 weeks
-
Available Biological Specimens:
-
Blood, serum, or plasma
-
DNA
-
Peripheral Blood Mononuclear Cells
-
How to Request Access: Email study contact
-
Available Data Description: Clinical and immunological data
-
Optional Additional Comments: If "Elite" is removed from the "Elite Controllers" Keyword, then it would apply to this study.
See also:
Blood, serum, and plasma, DNA, HIV+, Brigham and Women's Hospital, Studies < 1000 Participants, Studies Started Post-2005, Domestic, International, Jonathan Li